Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions to customers. It develops, manufactures, and markets electronic implantable hearing devices. The company’s products are suited for people with conductive hearing loss, mixed hearing loss or single-sided deafness. Its major products include cochlear implant systems, bone conduction systems, acoustic implants, bone-anchored prosthetics and wireless accessories. It has manufacturing facilities in Sweden, China, Malaysia and Australia. The company markets its products through subsidiaries, local offices, distributors and agents. Cochlear is headquartered in Sydney, New South Wales, Australia.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Cochlear Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Cochlear Ltd Company Overview
- Cochlear Ltd Company Snapshot
- Cochlear Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Cochlear Ltd - Pipeline Analysis Overview
- Business Description
- Cochlear Ltd - Key Facts
- Cochlear Ltd - Major Products and Services
- Cochlear Ltd Pipeline Products by Development Stage
- Cochlear Ltd Ongoing Clinical Trials by Trial Status
- Cochlear Ltd Pipeline Products Overview
- Cochlear Implant With Dexamethasone Eluting Electrode Array
- Cochlear Implant With Dexamethasone Eluting Electrode Array Product Overview
- Cochlear Implant With Dexamethasone Eluting Electrode Array Clinical Trial
- Cochlear Osia OSI300 Implant
- Cochlear Osia OSI300 Implant Product Overview
- CP1110 Sound Processor
- CP1110 Sound Processor Product Overview
- CP1110 Sound Processor Clinical Trial
- Custom Sound Pro Fitting Software
- Custom Sound Pro Fitting Software Product Overview
- Nucleus Profile Plus
- Nucleus Profile Plus Product Overview
- OSIA 2 System
- Product Status
- UmboMic
- UmboMic Product Overview
- Cochlear Ltd - Key Competitors
- Cochlear Ltd - Key Employees
- Cochlear Ltd - Key Employee Biographies
- Cochlear Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Cochlear Ltd, Recent Developments
- Jul 02, 2024: Implantable microphone could lead to fully internal cochlear implants
- Jul 02, 2024: Implantable Microphone Could Lead to Fully Internal Cochlear Implants
- Apr 28, 2024: Cochlear Americas Receives Additional 510(K) Clearance For Cochlear Osia System
- Apr 22, 2024: Cochlear secures FDA clearance for Osia System for children aged five
- Sep 14, 2023: Cochlear Americas Receives Additional 510(k) Clearance for Instrument Case P1340904
- Sep 05, 2023: Cochlear Receives Additional 510(k) Clearance for Cochlear Osia Fitting Software 2
- Sep 05, 2023: Cochlear Receives Additional 510(k) Clearance for Cochlear Osia 2 Sound Processor
- Sep 05, 2023: Cochlear Receives Additional 510(k) Clearance for Cochlear Osia System
- Aug 24, 2023: Cochlear Americas Receives 510(k) Clearance for Cochlear Osia OSI300 Implant
- Aug 24, 2023: Cochlear Americas Receives 510(k) Clearance for Cochlear Osia Smart App
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Cochlear Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Cochlear Ltd Pipeline Products by Equipment Type
- Cochlear Ltd Pipeline Products by Indication
- Cochlear Ltd Ongoing Clinical Trials by Trial Status
- Cochlear Ltd, Key Facts
- Cochlear Ltd, Major Products and Services
- Cochlear Ltd Number of Pipeline Products by Development Stage
- Cochlear Ltd Pipeline Products Summary by Development Stage
- Cochlear Ltd Ongoing Clinical Trials by Trial Status
- Cochlear Ltd Ongoing Clinical Trials Summary
- Cochlear Implant With Dexamethasone Eluting Electrode Array - Product Status
- Cochlear Implant With Dexamethasone Eluting Electrode Array - Product Description
- Cochlear Implant With Dexamethasone Eluting Electrode Array - A Pivotal, Prospective, Multi-centre, Randomised Controlled, Blinded Investigation Evaluating the Efficacy of a Dexamethasone Eluting Slim Straight Electrode (CI622D) in the Reduction of Impedance as Compared to a Standard Slim Straight Electrode (CI622) in a Newly Implanted Adult Population With Post-linguistic, Bilateral, Moderately Severe to Profound Sensorineural Hearing Loss
- Cochlear Osia OSI300 Implant - Product Status
- Cochlear Osia OSI300 Implant - Product Description
- CP1110 Sound Processor - Product Status
- CP1110 Sound Processor - Product Description
- CP1110 Sound Processor - A Pre-Market, Open-Label, Within-Subject, Interventional Study Examining Acceptability in Actual-Use Scenarios of CP1110 Sound Processor, CP1175 Sound Processor and Associated System Components in Experienced Adult CI1000 Series Cochlear Implant Recipients (LUMINA)
- Custom Sound Pro Fitting Software - Product Status
- Custom Sound Pro Fitting Software - Product Description
- Nucleus Profile Plus - Product Status
- Nucleus Profile Plus - Product Description
- Product Status
- OSIA 2 System - Product Description
- UmboMic - Product Status
- UmboMic - Product Description
- Cochlear Ltd, Key Employees
- Cochlear Ltd, Key Employee Biographies
- Cochlear Ltd, Subsidiaries
- Glossary
- Cochlear Ltd Pipeline Products by Equipment Type
- Cochlear Ltd Pipeline Products by Development Stage
- Cochlear Ltd Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Widex Australia Pty Ltd
- Sonova Holding AG
- GN ReSound Pty. Ltd
- Starkey Hearing Technologies Inc
- Sonic Innovations Pty Ltd
- Rion Co Ltd
- Demant A/S
- Sophono, Inc
- MED-EL Elektromedizinische Gerate Gesellschaft mbH
